INFLAMMATORY MARKERS IN NEONATAL SEPSIS
Background: There is still an urgent medical need for the diagnosis of hyperinflammation associated with sepsis in the newborn. In the case of neonatal sepsis, everything is complicated by many factors that affect the biomarker analysis: a large variability in the degree of maturity at birth, features of the functioning of all organs and systems, and especially the immune system.
Aim: Our research is devoted to the study of biomarkers of inflammation in early neonatal sepsis.
Materials and methods: Observational cohort study. In the study up to 75 newborns treated in intensive care units are included. The criterion for defining a case of "sepsis" was a positive blood culture. The control group consisted of children with negative blood culture, who were treated in the intensive care unit. We used bacteriological and immunological research methods (flow cytometry for cell markers, immunofluorescence analysis of cytokines)
Statistical analysis was performed using the non-parametric Kruskal-Wallis test, Mann-Whitney test with Holm correction (R statistics). Categorical data were calculated using the Chi-square test.
Results: C reactive protein showed a good applicability in the case of early neonatal sepsis, in contrast to procalcitonin, which demonstrates an excellent specificity, has a low sensitivity and high variability.
Neither leukocytosis, leukopenia, leukocyte subpopulations showed reliable discriminatory characteristics. However, a simple and publicly available neutrophil-lymphocyte index presented 80% specificity and generally proved to be a reliable index. The basic immune status is characterized only by a decrease in CD8 lymphocytes. Cytokines are standard markers of inflammation; however, it is difficult to obtain meaningful differences due to the abundance of cofactors that affect their levels. But at the same time, sCD40 and IL-17a, which have not been sufficiently studied in neonatal sepsis, should be recognized as extremely promising.
Conclusions: The study of inflammation markers of early neonatal sepsis showed that hyperinflammatory syndrome prevails in the pathogenesis of neonatal sepsis. Significant variation in serum markers of newborns, including the classic ones (CRP, PCT, NRL, interleukins 6, 8), suggests that they should be used with caution for diagnosis. There is a need to study new new diagnostic targets based on markers of inflammation. According to the results of our study, sCD40 and IL-17a, which were previously insufficiently studied in neonatal sepsis, should be recognized as such targets as extremely promising markers.
Number of Views: 226
Category of articles:
Original articles
Bibliography link
Akhmaltdinova L.L., Kolesnichenko S.I., Lavrinenko A.V., Zhumadilova Zh.A., Avdienko O.V., Panibratec L.G., Vinogradskaya E.V. Inflammatory markers in neonatal sepsis // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp. 44-50. doi 10.34689/SH.2022.24.4.006Related publications:
VALIDATION OF THE KAZAKH VERSION OF THE DEPRESSION ANXIETY STRESS SCALE (DASS-21) IN MEDICAL FACULTY STAFF SAMPLE: THE PILOT STUDY
PREDICTIVE VALUE OF PSYCHOMETRIC TESTING IN CONTEXT OF CREATING ADAPTIVE ENVIRONMENT FOR HIGHER MEDICAL EDUCATION
ASSESSMENT OF STUDENTS' AWARENESS ABOUT THE HARMS OF MICROPLASTICS ON THE HUMAN BODY
THE IMPACT OF COMPLAINTS ON QUALITY OF LIFE, PSYCHOLOGICAL WELL-BEING AND HEALTH OF MEDICAL WORKERS
DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FOR PATIENTS "STUDYING THE OPINION OF PATIENTS' SATISFACTION WITH NURSE INDEPENDENT APPOINTMENT AT THE LEVEL OF PRIMARY HEALTH CARE"